Actuate Therapeutics Inc (ACTU) vs Rein Therapeutics Inc. (RNTX)
A side-by-side comparison of Actuate Therapeutics Inc and Rein Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACTU
Actuate Therapeutics Inc
$0.83HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
RNTX
Rein Therapeutics Inc.
$0.82HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — ACTU vs RNTX
growth of $100 · dividends reinvested · last 2yACTU -89.9% (-68.3%/yr)RNTX -61.1% (-37.6%/yr)RNTX compounded faster over this window
ACTU RNTX
ACTU vs RNTX: by the numbers
- •RNTX is the larger company ($23M vs $20M market cap).
Metrics side by side
Valuation
| Metric | ACTU | RNTX |
|---|---|---|
| P/B ratio | 19.98 | 2.25 |
Profitability
| Metric | ACTU | RNTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -2067.81% | -487.90% |
| ROIC | -1489.99% | -36.89% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.